[ad_1]
BRASILIA – The President of Chamber of Deputies, Rodrigo Maia (DEM-RJ), said that it hopes to vote until Thursday 10, a provisional measure by which the Chamber may participate in the definition of the vaccination strategy against COVID-19. OR Ministry of Health He hopes to start immunization only in March, but countries in Europe and even Latin America, such as Mexico, are already organizing to start this month. The government of São Paulo announced the start of vaccination for January, but the purchased immunizer, the Coronavac, the effectiveness results have not yet been published.
“It is very serious that Brazil does not immediately define a plan, it does not decide definitively which is the way,” said the president of the Chamber, at a press conference on Monday 7. If no vote is taken on Thursday, the maximum deadline will be it is for the text to be deliberated early next week.
Maia did not mention which MP would be, but one of the measures awaiting deliberation by the Chamber is 1.003, which authorizes the federal government to join Global Covid-19 Vaccine Access Instrument – Covax Facility, a consortium for access to immunizations led by World Health Organization.
When asked if this vote could establish a timetable, Maia replied that it could and that she had already asked the rapporteur to speak to the ministry about the matter. According to the president of the Chamber, it would be better to organize this agenda in conjunction with the federal government, but the Legislative, “anyway”, will continue this debate. “We will move forward anyway, especially since the STF it will also advance. And I think the best way is to do it in an integrated way between the Executive, the Legislative and then the final decision of the Supreme Court, “said Maia.
“Ideally, we organize this together, that we have a plan for this because people are going to start, and a certain panic has already begun, a great panic,” he continued. The deputy cited the possibility that people who already had covid-19 could become contaminated again. “And the second time is worse than the first,” he said.
He was asked if the law could apply to the vaccine according to which National Health Surveillance Agency (Anvisa) has up to 72 hours to approve COVID-19 drugs and equipment already released for use abroad, Maia replied that “in theory, it could.” However, he stressed that an “objective rule” would provide more security.
[ad_2]
